180 related articles for article (PubMed ID: 7858107)
1. Relationship between antigens and IgG subclasses in bullous pemphigoid.
Suzuki M; Harada S; Kanazawa K; Kitajima Y; Yaoita H
Autoimmunity; 1994; 18(3):217-25. PubMed ID: 7858107
[TBL] [Abstract][Full Text] [Related]
2. Bullous pemphigoid IgG2 and IgG4 antibodies have a capability to inhibit a transient increase of intracellular Ca2+ induced by bullous pemphigoid IgG1 antibody.
Suzuki M; Harada S; Yaoita H; Nakagawa H
Autoimmunity; 1999; 30(2):85-91. PubMed ID: 10435721
[TBL] [Abstract][Full Text] [Related]
3. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
Allen J; Shears E; Powell J; Wojnarowska F
Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
[TBL] [Abstract][Full Text] [Related]
4. IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA.
Rico MJ; Korman NJ; Stanley JR; Tanaka T; Hall RP
J Immunol; 1990 Dec; 145(11):3728-33. PubMed ID: 1700993
[TBL] [Abstract][Full Text] [Related]
5. The predominance of IgG4 in prodromal bullous pemphigoid.
Lamb PM; Patton T; Deng JS
Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
[TBL] [Abstract][Full Text] [Related]
6. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
Döpp R; Schmidt E; Chimanovitch I; Leverkus M; Bröcker EB; Zillikens D
J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301
[TBL] [Abstract][Full Text] [Related]
7. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
Chimanovitch I; Hamm H; Georgi M; Kroiss M; Stolz W; Apitz C; Bröcker EB; Zillikens D
Arch Dermatol; 2000 Apr; 136(4):527-32. PubMed ID: 10768652
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of immunoglobulins G1 and G4 targeting the non-collagenous 16A domain of BP180 reflect bullous pemphigoid activity and predict bad prognosis.
Zhou XP; Liu B; Xu Q; Yang Y; He CX; Zuo YG; Liu YH
J Dermatol; 2016 Feb; 43(2):141-8. PubMed ID: 26300465
[TBL] [Abstract][Full Text] [Related]
9. Purification of bullous pemphigoid IgG subclasses and their capability for complement fixation.
Suzuki M; Harada S; Yaoita H
Acta Derm Venereol; 1992 Aug; 72(4):245-9. PubMed ID: 1357875
[TBL] [Abstract][Full Text] [Related]
10. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus.
Shirakata Y; Shiraishi S; Sayama K; Miki Y
J Dermatol; 1990 Nov; 17(11):661-6. PubMed ID: 2094743
[TBL] [Abstract][Full Text] [Related]
11. IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation.
Yamada H; Hashimoto T; Nishikawa T
J Invest Dermatol; 1989 Apr; 92(4):585-7. PubMed ID: 2649595
[TBL] [Abstract][Full Text] [Related]
12. Equine bullous pemphigoid IgG autoantibodies target linear epitopes in the NC16A ectodomain of collagen XVII (BP180, BPAG2).
Olivry T; Borrillo AK; Xu L; Dunston SM; Slovis NM; Affolter VK; Demanuelle TC; Chan LS
Vet Immunol Immunopathol; 2000 Jan; 73(1):45-52. PubMed ID: 10678397
[TBL] [Abstract][Full Text] [Related]
13. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses.
Laffitte E; Skaria M; Jaunin F; Tamm K; Saurat JH; Favre B; Borradori L
Br J Dermatol; 2001 Apr; 144(4):760-8. PubMed ID: 11298534
[TBL] [Abstract][Full Text] [Related]
15. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
Brooks WS; Lee YY; Abell E; Deng JS
J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
[TBL] [Abstract][Full Text] [Related]
16. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.
Iwasaki T; Olivry T; Lapiere JC; Chan LS; Peavey C; Liu YY; Jones JC; Ihrke PJ; Woodley DT
Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213
[TBL] [Abstract][Full Text] [Related]
17. Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens.
Trüeb RM; Didierjean L; Fellas A; Elias A; Borradori L
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):338-44. PubMed ID: 10025864
[TBL] [Abstract][Full Text] [Related]
18. A predominant IgG4 subclass may be responsible for false-negative direct immunofluorescence in bullous pemphigoid.
Buschman KE; Seraly M; Thong HY; Deng JS; Draviam RP; Abernethy JL
J Cutan Pathol; 2002 May; 29(5):282-6. PubMed ID: 12100628
[TBL] [Abstract][Full Text] [Related]
19. In situ-bound antibodies eluted from the skin of patients with bullous pemphigoid are preferentially directed against the 230-kD bullous pemphigoid antigen.
Korman NJ
J Invest Dermatol; 1995 Dec; 105(6):824-30. PubMed ID: 7490478
[TBL] [Abstract][Full Text] [Related]
20. Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid.
Seishima M; Izumi T; Kitajima Y
Eur J Dermatol; 1999; 9(1):39-42. PubMed ID: 9920986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
